ArticleCancer science2019

Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models.

Fei Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.